CAMBRIDGE, Mass., Aug. 29 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM) today announced that its presentation at the Thomas Weisel Partners 2007 Healthcare Conference will be webcast live and may be accessed by visiting the Investors section of the Company's website, http://www.millennium.com.
The presentation will review recent events, clinical pipeline updates, and upcoming milestones. The presentation will be delivered at 8:35 a.m. ET on Friday, September 7, 2007 from the Four Seasons Hotel in Boston, MA. The presentation will be archived for 30 days.
Millennium Pharmaceuticals, Inc., a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE(R) (bortezomib) for Injection, a novel cancer product, and has a robust clinical development pipeline of product candidates. The Company's research, development and commercialization activities are focused in two therapeutic areas: oncology and inflammation. By applying its knowledge of the human genome, understanding of disease mechanisms and industrialized drug discovery platform, Millennium is developing an exciting pipeline of innovative product candidates. The Company's website is http://www.millennium.com.
Editors' Note: This press release is also available under the Media section of the Company's website at: http://www.millennium.com.
|SOURCE Millennium Pharmaceuticals, Inc.|
Copyright©2007 PR Newswire.
All rights reserved